110991 ⎘
ssRNA viruses negative-sense; Details; Paramyxoviridae; Pneumovirus, e.g. human respiratory syncytial virus Methods of inactivation or attenuation
Sub-classes:RSV Vaccines with Truncated G-Protein Mucin Domains
#2ATTENUATION OF HUMAN RESPIRATORY SYNCYTIAL VIRUS BY GENOME SCALE CODON-PAIR DEOPTIMIZATION
#3Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
#4METHODS FOR INACTIVATING AND STORING RESPIRATORY SYNCYTIAL VIRUS
#5Respiratory syncytial virus having altered NS1 protein function and related materials and methods
#6Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
#7Respiratory syncytial virus with a genomic deficiency complemented in trans
#8Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
#9Respiratory syncytial virus with a genomic deficiency complemented in trans
#10Preparation of Negative-Stranded RNA Viruses By Electroporation
#11Recombinant RSV Virus Expression Systems And Vaccines
#12FUNCTIONAL MUTATION IN RESPIRATORY SYNCYTIAL VIRUS
#13PRODUCTION OF ATTENUATED NEGATIVE STRANDED RNA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES
#14Recombinant RSV Virus Expression Systems And Vaccines
#15Respiratory syncytial virus with a genomic deficiency complemented in trans
#16Functional Mutations In Respiratory Syncytial Virus
#17Recombinant RSV Virus Expression Systems And Vaccines
#18Recombinant RSV Virus Expression Systems And Vaccines
#19RECOMBINANT RSV VIRUS EXPRESSION SYSTEMS AND VACCINES
#20Functional Mutations In Respiratory Syncytial Virus
#21PRODUCTION OF ATTENUATED NEGATIVE STRANDED RNA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES
#22Preparation of Negative-Stranded RNA Viruses by Electroporation
#23Recombinant RSV Virus Expression Systems And Vaccines
#24Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
#25Recombinant RSV strains with altered G protein
#26Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
#27Process for increasing RSV surface glycoprotein yields using a mutant strain of RSV
#28Recombinant RSV virus expression systems and vaccines
#29Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
#30Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
#31Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
#32Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
#33Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences
#34Attenuated bovine respiratory syncytial virus
#35Functional mutations in respiratory syncytial virus
#36Recombinant RSV virus expression systems and vaccines
#37Recombinant RSV virus expression systems and vaccines
#38Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions
#39Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modulatory molecules
#40Attenuated chimeric respiratory syncytial virus
#41Subunit respiratory syncytial virus vaccine preparation
#42Recombinant RSV virus expression systems and vaccines